Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT A multiplex QIF assay was optimized on tissue ...

(RTTNews) - Akoya Biosciences, Inc. (AKYA), Thursday announced the launch of a new multiplex immunofluorescence or mIF assay to advance antibody-drug conjugate or ADC development in breast cancer, ...

Please provide your email address to receive an email when new articles are posted on . A novel assay may help direct antibody-drug conjugate therapy through measurements of HER2 and TROP2. Most ...

Hamamatsu Photonics of Japan and Massachusetts-based Vizgen have announced a strategic partnership intended to speed up research laboratory workflows. The collaboration will in particular aim to ...

Immunofluorescence staining enables the detection and localization of antigens in diverse types of tissues in various cell preparations. AMSBIO has now launched CellO-IF, an immunofluorescence ...